Alcon Files Form 20-F with U.S. Securities and Exchange Commission
2011年3月19日 - 7:04AM
ビジネスワイヤ(英語)
Alcon, Inc. (NYSE:ACL) has filed its Form 20-F annual report of
foreign private issuer with the U.S. Securities and Exchange
Commission (SEC). An electronic version of this annual filing is
available for review in the Investors and Media section of the
company’s web site or in the SEC’s EDGAR database at
www.sec.gov.
Investors may obtain a printed copy of Alcon’s audited financial
statements free of charge by contacting Alcon Investor Relations
either by phone, e-mail or in writing at the address below.
Alcon Investor Relations6201 South Freeway, MC TA7-5Fort Worth,
TX 76134Phone:
1-800-400-8599investor.relations@alconlabs.comwww.alcon.com
About Alcon
Alcon, Inc. is the world’s leading eye care company, with sales
of approximately $7.2 billion in 2010. Alcon, which has been
dedicated to the ophthalmic industry for 65 years, researches,
develops, manufactures and markets pharmaceuticals, surgical
equipment and devices, contacts lens solutions and other vision
care products that treat diseases, disorders and other conditions
of the eye. Alcon operates in 75 countries and sells products in
180 markets. For more information on Alcon, Inc., visit the
Company’s web site at www.alcon.com.
Alcon (NYSE:ACL)
過去 株価チャート
から 4 2024 まで 5 2024
Alcon (NYSE:ACL)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Alcon, Inc. (ニューヨーク証券取引所): 0 recent articles
その他のAlcon, Inc.ニュース記事